These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23897640)

  • 1. Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis.
    Cox MB; Bowden NA; Scott RJ; Lechner-Scott J
    Mult Scler; 2014 Apr; 20(4):489-91. PubMed ID: 23897640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation.
    Cox MB; Bowden NA; Scott RJ; Lechner-Scott J
    Mult Scler; 2013 Sep; 19(10):1268-74. PubMed ID: 23401127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of putative functional variants in the PLAU gene and the PLAUR gene with myocardial infarction.
    Xu J; Li W; Bao X; Ding H; Chen J; Zhang W; Sun K; Wang J; Wang X; Wang H; Yu H; Song W; Ma W; Zhang L; Wang C; Wang D; Hui R
    Clin Sci (Lond); 2010 Jul; 119(8):353-9. PubMed ID: 20518747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.
    Cetinsoy O; Anyanwu I; Krishnanand H; Natarajan G; Ramachandran N; Thomas A; Brookes KJ
    J Alzheimers Dis; 2024; 99(1):241-250. PubMed ID: 38669542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MMP1, MMP3, MMP9, and MMP12 polymorphisms with risk and clinical course of multiple sclerosis in a Polish population.
    Mirowska-Guzel D; Gromadzka G; Czlonkowski A; Czlonkowska A
    J Neuroimmunol; 2009 Sep; 214(1-2):113-7. PubMed ID: 19628284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of non-small cell lung cancer.
    Shih CM; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Lee YL
    Clin Chim Acta; 2011 Jan; 412(1-2):194-8. PubMed ID: 20937265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DBC1 re-expression alters the expression of multiple components of the plasminogen pathway.
    Louhelainen JP; Hurst CD; Pitt E; Nishiyama H; Pickett HA; Knowles MA
    Oncogene; 2006 Apr; 25(16):2409-19. PubMed ID: 16369496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of the plasminogen activator inhibitor-1 is associated with an increased risk of endometrial cancer.
    Su CK; Yeh KT; Yeh CB; Wang PH; Ho ES; Chou MC; Liu KC; Yang SF; Yi YC
    J Surg Oncol; 2011 Dec; 104(7):755-9. PubMed ID: 21761413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the association of urokinase plasminogen activator system gene polymorphisms with susceptibility and pathological development of hepatocellular carcinoma.
    Weng CJ; Tsai CM; Chen YC; Hsieh YH; Lin CW; Liu YF; Su SC; Chen MK; Yang SF
    Ann Surg Oncol; 2010 Dec; 17(12):3394-401. PubMed ID: 20706793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of urokinase-type plasminogen activator with asthma and atopy.
    Bégin P; Tremblay K; Daley D; Lemire M; Claveau S; Salesse C; Kacel S; Montpetit A; Becker A; Chan-Yeung M; Kozyrskyj AL; Hudson TJ; Laprise C
    Am J Respir Crit Care Med; 2007 Jun; 175(11):1109-16. PubMed ID: 17363771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control study.
    La Russa A; Cittadella R; De Marco EV; Valentino P; Andreoli V; Trecroci F; Latorre V; Gambardella A; Quattrone A
    J Neuroimmunol; 2010 Aug; 225(1-2):175-9. PubMed ID: 20471697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
    Benesová Y; Vasků A; Stourac P; Hladíková M; Beránek M; Kadanka Z; Novotná H; Bednarík J
    J Neuroimmunol; 2008 Dec; 205(1-2):105-9. PubMed ID: 18835646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between urokinase-plasminogen activator gene T4065C polymorphism and risk of mitral valve prolapse.
    Chou HT; Chen YT; Wu JY; Tsai FJ
    Int J Cardiol; 2004 Aug; 96(2):165-70. PubMed ID: 15262029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cAMP-ERK1/2 signaling pathway regulates urokinase-type plasminogen activator-induced bovine granulosa cell proliferation.
    Zhao Y; Yu B; Liu X; Hu J; Yang Y; Namei E; Yang B; Bai Y; Qian Y; Li H
    Reproduction; 2020 Dec; 160(6):853-862. PubMed ID: 33112787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 gene.
    Nischwitz S; Wolf C; Andlauer TF; Czamara D; Zettl UK; Rieckmann P; Buck D; Ising M; Bettecken T; Mueller-Myhsok B; Weber F
    J Neuroimmunol; 2015 Feb; 279():46-9. PubMed ID: 25670000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9.
    Martínez-Hernández MG; Baiza-Gutman LA; Castillo-Trápala A; Armant DR
    Reproduction; 2011 Feb; 141(2):227-39. PubMed ID: 21075828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.
    Sadovnick AD; Traboulsee AL; Bernales CQ; Ross JP; Forwell AL; Yee IM; Guillot-Noel L; Fontaine B; Cournu-Rebeix I; Alcina A; Fedetz M; Izquierdo G; Matesanz F; Hilven K; Dubois B; Goris A; Astobiza I; Alloza I; Antigüedad A; Vandenbroeck K; Akkad DA; Aktas O; Blaschke P; Buttmann M; Chan A; Epplen JT; Gerdes LA; Kroner A; Kubisch C; Kümpfel T; Lohse P; Rieckmann P; Zettl UK; Zipp F; Bertram L; Lill CM; Fernandez O; Urbaneja P; Leyva L; Alvarez-Cermeño JC; Arroyo R; Garagorri AM; García-Martínez A; Villar LM; Urcelay E; Malhotra S; Montalban X; Comabella M; Berger T; Fazekas F; Reindl M; Schmied MC; Zimprich A; Vilariño-Güell C
    G3 (Bethesda); 2016 Jul; 6(7):2073-9. PubMed ID: 27194806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis.
    Di Bernardo MC; Matakidou A; Eisen T; Houlston RS;
    Lung Cancer; 2009 Aug; 65(2):237-41. PubMed ID: 19117638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of urokinase-type plasminogen activator is interacting with plasminogen activator inhibitor-1 to raise risk of cervical neoplasia.
    Tee YT; Wang PH; Tsai HT; Lin LY; Lin HT; Yang SF; Hsieh YH; Ying TH
    J Surg Oncol; 2012 Aug; 106(2):204-8. PubMed ID: 22354580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.